ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NTHI vs VTVT // RSI-14 & 200D SMA MOMENTUM

NeOnc Technologies Holdings Inc. (NASDAQ) VS. vTv Therapeutics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: NTHI 2 — VTVT 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: NTHI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTHI VS. VTVT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NTHI VTVT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -21.93% -24.21% +2.28 NTHI /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -51.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 VTVT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 49.6 29.1 +20.50 NTHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $91.4M $95.5M -$4.1M VTVT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NTHI REV VTVT REV NTHI GROSS % VTVT GROSS % NTHI FCF VTVT FCF
FY 2025 $40.0K $91.9M — — -$20.4M -$25.3M
FY 2024 $83.0K $1.0M — — -$4.2M -$25.3M
FY 2023 — $71.4M — — — -$19.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTHI // BETA —
VTVT // BETA —